Berks Hematology Oncology Associates is a clinical research site located in West Reading, Pennsylvania, United States 19611.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
Berks Hematology Oncology Associates has participated in 6 clinical trials.
Therapeutic areas: Lymphoma, Follicular, Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Renal Cell Carcinoma.
Sponsors: SCRI Development Innovations, LLC, Millennium Pharmaceuticals, Inc., Hoosier Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in West Reading
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Berks Hematology Oncology Associates has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Berks Hematology Oncology Associates has 6 clinical trials on record. Their work covers Lymphoma, Follicular, Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Renal Cell Carcinoma.
Berks Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.